MedCity FemFwd: Opportunities in the Fertility Market
In this episode, we’re joined by Claire Love, deals strategy principal at PwC. We discuss PwC’s recent report showing the opportunities in the fertility and reproductive health market.
Women’s Oncology Market Could Reach $110B in 2030, but Gaps Remain
A new PwC report says the women's oncology market could reach $110 billion by 2030, though funding and care gaps remain.
presented by
Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
The Women’s Health Market Is Poised to Reach $600B by 2030. That’s if ‘We Do Nothing’
A PwC report finds that women’s health is evolving into a much larger, high-growth market as investment expands beyond reproductive care, though it remains underfunded and under-researched.
Medical Expenses Will Rise by 7% Next Year, Report Predicts
New research predicts that healthcare costs will increase by 7% next year. The estimate is higher than the projected medical cost trends in 2022 and 2023 — which were 5.5% and 6.0%, respectively.
PwC: Healthcare Deals Remained Strong in 2023 Despite Headwinds
In the 12 months leading up to May 15, health services deal volumes decreased just 4% from the year prior, a new report from PwC found. There was a 15% decrease in deal values.
Healthcare Deal Value Expected to Keep Decreasing in 2023, PwC says
The volume of healthcare deals has increased in 2022, driven in large part by private equity, according to a new PwC report. But deal values have been declining, a trend that is expected to continue into 2023.
presented by
Automation Didn’t Dehumanize Care. Bad Systems Did.
We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring.
Fine-tuning telehealth, addressing mental health take precedence for providers in 2021
As 2020 draws to a close, healthcare providers are strategizing for the new year and the new normal. Providers will need to retool their telehealth efforts and prepare to meet a burgeoning mental crisis, among other issues.
Employers must consider privacy protections as they roll out contact-tracing tools
Companies are rolling out suites of tools to monitor their workforce for Covid-19 cases. But even in the midst of a pandemic, there are still limitations on what information they can collect and how they can use it.
Geopolitical, economic concerns unlikely to stem pharma, life science industry capital deployment, report finds
Deal value for the third quarter fell sharply from what it was in the first and second quarter, but that was due to the absence of the large acquisitions that took place earlier this year rather than an overall downward trend.
More than half of patients willing to use digital therapeutic, study says
The report also found that 56 percent of physicians have brought up the potential for a digital therapy as an option for their patients, and 26 percent have discussed the option after a patient brought it up.
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
Amazon’s latest healthcare foray is a major step into health informatics
A new software service from the company called Amazon Comprehend Medical uses machine learning and natural language processing to extract relevant medical information from doctors' notes, clinical trial reports and patient health records.
The 10 largest biotech and devices VC investments in Q2
The most recent MoneyTree report from PwC and CB Insights highlights the biggest biotech-related and medical devices VC deals in Q2, which include investments in companies like Grail, Allogene Therapeutics, RefleXion Medical and Mevion Medical Systems.
VICE documentary shows new frontier in drug pricing debate: DIY drugs
Experts discuss the multitude of factors feeding high drug prices and some of the solutions that policymakers have proposed.
What happens when AI fails? Healthcare startups share their failsafe maneuvers
In a panel discussion at MedCity INVEST, a group of health tech professionals and entrepreneurs offered some insight when machine learning algorithms fail to do what they were assigned to do.
These are the hottest trends in healthcare M&A and VC investing
PwC partner Greg Vlahos and Matter CEO Steven Collens weighed in on how the biotech and health IT spaces had a great quarter as far as investment dollars are concerned.